Aptose Biosciences enters retention agreements with CEO, CFO, and CMO totaling ~$698K upon change of control

Aptose Biosciences Inc.

CEO William Rice receives $331,496 retention grant; CFO Fletcher Payne $167,059; CMO Rafael Bejar $199,947.
Payments due within 5 days of a change of control closing.
Grants forfeited if executive is not actively employed at change of control closing.
Aims to reward, retain, and incentivize leadership team for long-term shareholder value.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.